The company received the decision on June 16 to issue a warning letter for nine people, such as sui chung, which was issued by the shandong provincial regulatory bureau, the medical website announced on June 21. Warning letter showed that SuiChong wait nine performance commitment for failing to perform the duty of performance compensation constitute extended fails to fulfill its commitments, by regulators to issue a warning letter, and the related credit archives is credited to securities and futures market. At the same time, regulators have urged the relevant parties to meet their performance compensation obligations as soon as possible.
In 2014, xinhua bought an 85 per cent stake in chengdu yingde by issuing shares and paying cash, and signed the profit forecast compensation agreement with nine people, including sui chung, in 2014. At the time, the company promised to make a net profit of no less than 45.8 million yuan in 2016. If the net profit is not reached, the performance commitment will pay the compensation to xinhua medical treatment.
According to the survey, chengdu yingde's net profit for 2016 was rmb4582.7m, which was 96.37.83 million yuan lower than promised net profit. According to the profit forecast compensation agreement, the performance commitments should meet the compensation obligations of xinhua medical service before June 1 this year. But as of this date, the performance commitments have not fulfilled the corresponding compensation obligations.
In this regard, the shandong securities bureau believes that the above-mentioned actions of nine people, such as sui chung, as a performance commitment, constitute a period of unfulfilled commitment. According to the relevant regulations, the decision to the sui chung and other nine people will be warned, and the relevant information will be recorded in the securities futures market integrity records. At the same time, the regulator urged the nine people, such as sui chung, to strictly abide by the relevant laws and regulations, earnestly fulfill their own public commitments and fulfill their performance compensation obligations as soon as possible.
It is worth noting that the xinhua medical after completing the acquisition, chengdu German for three consecutive years have failed to meet performance commitment, its commitment to the 2014 and 2015 when the performance value of the ratio of 83.25% and 75.99%, respectively.
Reporters noted that the company's 2016 annual report showed that chengdu yingde's 2015 performance compensation was not fully implemented. The company has filed a lawsuit against the people's court of zibo high-tech industry development zone in shandong province and has won a successful civil judgment.
In early June, xinhua medical service received an inquiry letter from the Shanghai stock exchange because of the failure of performance commitments to meet the 2016 performance compensation payment. In response to inquiries, the results promised said, because of its stock market value, to xinhua medical pay compensation performance is beyond the scope of personal affordable, thus unable to fulfill the performance compensation commitment. |
